We observed that cisplatin activated STING signalling in cervical cancer cells is related to cisplatin‐induced proinflammatory factor expression, but may not be related to IFI16/NF‐κB resistance to cisplatin‐induced apoptosis. This evidence concerns the gene IFI16 and cervical carcinoma.